Draft:CELforPharma
 | Review waiting, please be patient.
This may take 3 months or more, since drafts are reviewed in no specific order. There are 3,396 pending submissions waiting for review.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
Reviewer tools
|
Comment: In accordance with the Wikimedia Foundation's Terms of Use, I disclose that I have been paid by my employer for my contributions to this article. MMutto (talk) 12:18, 3 June 2026 (UTC)CELforPharma is a Belgium-based provider of professional training programmes for the pharmaceutical, biotechnology, medical device, and healthcare industries.[1][2][3]
Founded in 2005, the company offers short-format open-enrolment and in-house courses on topics including pricing, HEOR & market access, medical affairs, marketing, and business development & licensing.[2][3][4][5]
History
[edit]CELforPharma was founded in Belgium in 2005 and is lead by Inge Cornelis and Annelies Swaan.[1] The company was established to provide professional education for professionals in market-facing roles across the pharmaceutical, biotech, medical device, and healthcare sectors.[1][2][5]
Over time, CELforPharma expanded its portfolio of open-enrolment and in-house programmes and attracted participants from multiple countries.[2]
Activities and services
[edit]CELforPharma provides short-format professional training programmes for organisations and professionals in the life sciences sector.[1][4]
Its portfolio includes 1- and 2-day open-enrolment courses as well as customised in-house training programmes for pharmaceutical, biotechnology, medical device, and healthcare companies.[1] The courses are delivered in person and through live online formats and they cover areas including pricing, HEOR & market access, medical affairs, marketing, and business development & licensing.[2][3][6][7][5]
CELforPharma also organises educational webinars on topics related to the life sciences industry.[8][9]
Expert faculty and collaborations
[edit]CELforPharma delivers its programmes through a faculty of consultants, researchers, and industry specialists active in the life sciences sector, covering areas including market access, health economics and outcomes research (HEOR), medical affairs, and commercial strategy.[10][6][5]
Faculty members include:
- Lieven Annemans: professor of health economics at Ghent University and former president of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).[11][12]
- Thomas Wilke: professor at Wismar University and head of its institute for Pharmacoeconomics and Drug Logistics, with expertise in real-world evidence and pharmacoeconomics research.[13][14]
- Neal Hansen: co-author of Pharmaceutical Lifecyle Management: Making the Most of Each and Every Brand.[15]
- Patrik Frei: founder and CEO of Venture Specialist, a Swiss firm specialisig in the independent valuation of life sciences companies and products, and speaker at BIO International Convention.[16]
References
[edit]- ^ a b c d e "About CELforPharma". www.celforpharma.com. Retrieved 2026-05-26.
- ^ a b c d e "C.E.L.forpharma - PMLiVE". pmlive.com. Retrieved 2026-05-26.
- ^ a b c "CELforPharma". PharmiWeb.com. Retrieved 2026-05-27.
- ^ a b Setia, Sajita; Ryan, Nicola J.; Nair, Prasad S.; Ching, Elma; Subramaniam, Kannan (2018). "Evolving role of pharmaceutical physicians in medical evidence and education". Advances in Medical Education and Practice. 9: 777–790. doi:10.2147/AMEP.S175683. ISSN 1179-7258. PMC 6223344. PMID 30464675.
- ^ a b c d "Partner Courses - PM Society". 2022-08-10. Retrieved 2026-06-03.
- ^ a b "CELforPharma". MYMA. Retrieved 2026-05-26.
- ^ "CELforPharma". www.findcourses.co.uk. Retrieved 2026-05-27.
- ^ "CELforPharma Webinars". www.celforpharma.com. Retrieved 2026-05-26.
- ^ "Trainings/Webinars Archives". Inpharmation. Retrieved 2026-05-27.
- ^ "Our Faculty". www.celforpharma.com. Retrieved 2026-05-27.
- ^ "prof. Lieven Annemans (PhD)". CRIG. Retrieved 2026-05-27.
- ^ "Past Presidents Council". ISPOR.org. Retrieved 2026-06-03.
- ^ "Thomas WILKE | Wismar University of Applied Sciences, Wismar | HS Wismar | Research profile". ResearchGate. Archived from the original on 2026-02-23. Retrieved 2026-06-03.
- ^ "Startseite - IPAM". www.ipam-wismar.de. Retrieved 2026-06-03.
- ^ Ellery, Tony; Hansen, Neal (2012-05-11). Pharmaceutical Lifecycle Management: Making the Most of Each and Every Brand (1 ed.). Wiley. doi:10.1002/9781118266755. ISBN 978-0-470-48753-2.
- ^ "Patrik Frei". BIO International Convention 2026. Retrieved 2026-06-03.